HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute antibiotically induced neutropenia: A systematic review of case reports.

AbstractAIMS:
Acute neutropenia induced by antibiotics is a rare side effect of this frequently prescribed class of drugs. We aim to find similarities and differences between reported cases.
METHODS:
Through a database search (PubMed, 1968-2020), we identified published case reports and extracted, among other data, patient demographics, duration of treatment with the respective agent, and duration of recovery.
RESULTS:
Overall, 83 cases were included. Neutropenia developed after a median (min-max) of 21 (17.5-28.5) days of treatment and was resolved after a median (min-max) of 6 (3.0-8.75) days. Vancomycin and ceftaroline emerged as the two most commonly described antibiotics. In 51.8% of cases, the suspected antibiotic was discontinued; in 37.4% of cases, it was substituted by another agent. Only three case reports mentioned death as a result of neutropenia. The use of granulocyte colony-stimulating growth factors (CSFs) shortened the duration of neutropenia and improved outcome for patients' health.
CONCLUSION:
Neutropenia induced by antibiotics remains a rare or rarely reported side effect. Long-term and high-dose treatment regimens expose a higher risk of development. Thus, regular full blood counts are advised during therapy.
AuthorsJulian M Holz, Alon V Chevtchenko, Aleksandra Aitullina
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 88 Issue 5 Pg. 1978-1984 (05 2022) ISSN: 1365-2125 [Electronic] England
PMID34897762 (Publication Type: Case Reports, Journal Article, Review, Systematic Review)
Copyright© 2021 British Pharmacological Society.
Chemical References
  • Anti-Bacterial Agents
  • Granulocyte Colony-Stimulating Factor
Topics
  • Anti-Bacterial Agents (adverse effects)
  • Drug-Related Side Effects and Adverse Reactions
  • Granulocyte Colony-Stimulating Factor (adverse effects)
  • Humans
  • Neutropenia (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: